Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins

Drug Development and Industrial Pharmacy

Volumn 41, Issue 6, 2015, Pages 1006-1016

  Samprasit, Wipada ^a   Akkaramongkolporn, Prasert ^a   Ngawhirunpat, Tanasait ^a   Rojanarata, Theerasak ^a   Opanasopit, Praneet ^a  

^a SILPAKORN UNIVERSITY   (Thailand)

Author keywords

Cyclodextrin; Ion exchange resins; Meloxicam; Oral disintegrating tablet; Taste masking

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ION EXCHANGE RESIN; MELOXICAM; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; TABLET; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ARTICLE; BITTER TASTE; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FRIABILITY; TABLET HARDNESS; TABLET THICKNESS; CHEMISTRY; CONTROLLED STUDY; DRUG STORAGE; HARDNESS; MEDICINAL CHEMISTRY; ORAL DRUG ADMINISTRATION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SOLUBILITY; TABLET; TASTE;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG STABILITY; DRUG STORAGE; HARDNESS; ION EXCHANGE RESINS; SOLUBILITY; TABLETS; TASTE; THIAZINES; THIAZOLES;

EID: 84930526421     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2014.922573     Document Type: Article

References (42)

1. Sastry SV, Nyshadham JR, Fx JA. Recent technological advances in oral drug delivery. A review. Pharm Sci Technol Today 2000;3: 138-45.
2. Hirani JJ, Rathod DA, Vadalia KR. Orally disintegrating tablets: a review. Trop J Pharm Res 2009;8:161-72.
3. Mohapatra A, Parikh RK, Gohel MC. Formulation, development and evaluation of patient friendly dosage forms of metformin, Part-I: orally disintegrating tablets. Asian J Pharm 2008;2:167-71.
4. Bhise K, Shaikh S, Bora D. Taste Mask, design and evaluation of an oral formulation using ion exchange resin as drug carrier. AAPS PharmSciTech 2008;9:557-62.
5. Anand V, Kandarapu R, Garg S. Ion-exchange resins: carrying drug delivery forward. Drug Discov Today 2001;6:905-14.
6. Burke GM, Mendes RW, Jambhekar SS. Investigation of the application of ion exchange resins as a sustained release drug delivery system for propranolol hydrochloride. Drug Dev Ind Pharm 1986;12:713-32.
7. Leea CW, Kima SJ, Youna YS, et al. Preparation of bitter taste masked cetirizine dihydrochloride/b-cyclodextrin inclusion complex by supercritical antisolvent (SAS) process. J Supercrit Fluid 2010;5: 348-57.
8. Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007;59:645-66.
9. Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996;85: 1017-25.
10. The United State Pharmacopoeia XXXII/National Formulation XXVII. Rockville (MD): The United States Pharmacopoeial Convention; 2009.
11. Kunin R. Ion exchange resins. New York: John Wiley & Sons, Inc.; 1963.
12. Sriwongjanya M, Bodmeier R. Entrapment of drug-loaded ionexchange particles within polymeric microparticles. Int J Pharm 1997;158:29-38.
13. Samprasit W, Rojanarata T, Akkaramongkolporn P, et al. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex. Drug Dev Ind Pharm 2013;39: 1672-80.
14. Job P. Job's plot analyses for the 2-CG and 3-CG complexes were consistent with 1:1 stoichiometry. Ann Chim 1928;9:113-34.
15. Guo X, Chang RK, Hussain MA. Ion-exchange resins as drug delivery carriers. J Pharm Sci 2009;98:3886-902.
16. Peh KK, Wong CF. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci 1999;2:53-61.
17. Fu Y, Jeong SH, Park K. Preparation of fast-dissolving tablets based on mannose. ACS Symp Ser 2006;924:340-51.
18. Bi Y, Sunada H, Yonezawa Y, et al. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull 1996;44:2121-7.
19. Luger P, Daneck K, Trummlitz WEG, Wagner K. Structure and physicochemical properties of meloxicam, a new NSAID. Eur J Pharm Sci 1996;4:175-87.
20. Pisal S, Zainnuddin R, Nalawade P, et al. Molecular properties of ciprofloxacin-Indion 234 complexes. AAPS PharmSciTech 2004;5: 1-8.
21. Sriwongjanya M, Bodmeier R. Entrapment of drug-loaded ionexchange particles within polymeric microparticles. Int J Pharm 1997;158:29-38.
22. Dowex product literature. Available from: http://www.dow.com [last accessed 26 Nov 2012].
23. Jeong SH, Park K. Drug loading and release properties of ionexchange resin complexes as a drug delivery matrix. Int J Pharm 2008;361:26-32.
24. Higuchi T, Kristiansen H. Binding specificities between small organic solutes in aqueous solutions: classification of some solutes onto two groups according to binding tendencies. J Pharm Sci 1970; 59:1601-8.
25. Obaidat AA, Khanfar RA, Khawam MN. The effect of b-cyclodextrin on the solubility and dissolution rate of meloxicam and investigation of the driving force for complexation using molecular modeling. J Incl Phenom Macrocycl Chem 2009;63:273-9.
26. Sinko PJ. Martin's physical pharmacy and pharmaceutical sciences. London: Lippincott Williams & Wilkins; 2011:197-222.
27. Jug M, Becírević-Lacán M. Influence of hydroxypropylb-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur J Pharm Sci 2004;21:251-60.
28. Sheshala R, Khan N, Chitneni M, Darwis Y. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants. Arch Pharm Res 2011;34:1945-56.
29. Fenyresi E, Shirankura O, Szejtli J, Nagai T. Properties of cyclodextrin polymer as a tableting aid. Chem Pharm Bull 1984; 32:665-9.
30. Ghorab MM, Abdel-Salam HM, El-Sayad MA, Mekhel MM. Tablet formulation containing meloxicam and b-cyclodextrin: mechanical characterization and bioavailability evaluation. AAPS PharmSciTech 2004;5:1-6.
31. Rudnic EM, Rhodes CT, Welsh S, Bernardo P. Evaluation of the mechanism of disintegrant action. Drug Dev Ind Pharm 1982;8: 87-109.
32. Amberlite product literature. Available from: http://www.rohmhaas.-com [last accessed 26 Nov 2012].
33. Akkaramongkolporn P, Ngawhirunpat T, Nunthanid J, Opanasopit P. Effect of a pharmaceutical cationic exchange resin on the properties of controlled release diphenhydramine hydrochloride matrices using Methocel K4M or Ethocel 7cP as matrix formers. AAPS PharmSciTech 2008;9:899-908.
34. Sriwongjanya M, Bodmeier R. Effect of ion exchange resins on the drug release from matrix tablets. Eur J Pharm Biopharm 1998;46: 321-7.
35. Pattarakan N, Opanasopit P, Ngawhirunpat T, Akkaramongkolporn P. Application of ion exchange resins as tablet disintegrants. The 26th Annual Research Conference in Pharmaceutical Science, 04 December 2009, Bangkok, Thailand.
36. Kornblum SS, Stoopak SB. A new tablet disintegrating agent: crosslinked polyvinylpyrrolidone. J Pharm Sci 1973;62:43-9.
37. Jivraj M, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharm Sci Tech Today 2000;3:58-62.
38. Narazaki R, Harada T, Takami N, et al. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull 2004;52:704-7.
39. Bi Y, Hisakadzu S. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull 1996;44:2121-7.
40. Jinichi F, Etsuo Y, Yasuo Y, Terada K. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int J Pharm 2006;310:101-9.
41. Akkaramongkolporn P, Yononemochi E, Terada K. Molecular state of chlorpheniramine in resinates. Chem Pharm Bull 2000;48:231-4.
42. Dahiya S, Pathak K. Influence of amorphous cyclodextrin derivatives on aceclofenae release from directly compressible tablets. Pharmazie 2007;62:278-83.